Novel Radiomic Measurements of Tumor-Associated Vasculature Morphology on Clinical Imaging as a Biomarker of Treatment Response in Multiple Cancers
Nathaniel Braman(Tempus Labs (United States)), Anant Madabhushi(Emory University), Patrick Leo(Case Western Reserve University), Manasa Vulchi(Cleveland Clinic), Donna Plecha(University Hospitals of Cleveland), Mohammadhadi Khorrami(Case Western Reserve University), Prateek Prasanna(Case Western Reserve University), Amit Gupta(University of Washington), Pingfu Fu(Medical College of Wisconsin), Prantesh Jain(Roswell Park Comprehensive Cancer Center), Vamsidhar Velcheti(Cleveland Clinic), Kaustav Bera(University Hospitals of Cleveland), Jame Abraham(Cleveland Clinic), Mehdi Alilou(Case Western Reserve University), Nathan A. Pennell(Cleveland Clinic), Maryam Etesami(Yale University), Paulette Turk(Cleveland Clinic)
Cited by 41
Related Papers
Clinical impact of COVID-19 on patients with cancer (CCC19): a cohort study
|The Lancet|2020|1.8k
Sotorasib for Lung Cancers with <i>KRAS</i> p.G12C Mutation
|New England Journal of Medicine|2021|1.8k
Efficacy of Selpercatinib in <i>RET</i> Fusion–Positive Non–Small-Cell Lung Cancer
|New England Journal of Medicine|2020|835
Predicting cancer outcomes with radiomics and artificial intelligence in radiology
|Nature Reviews Clinical Oncology|2021|810
Programmed death ligand-1 expression in non-small cell lung cancer
|Laboratory Investigation|2013|753